Depletion of the Antioxidant Ergothioneine by Critical Illness and Continuous Renal Replacement Therapy
Kidney and Dialysis · 14.07.2026 · 6 (3) · 48
DOI: 10.3390/kidneydial6030048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney and Dialysis, online erschienen am 14.07.2026. Verfasst von William A Vasquez Espinosa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Stanford University, Palo Alto, CA 94304, USA. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NINDS NIH HHS, National Kidney Foundation.
Abstract (Originalsprache)
Background
Ergothioneine is a diet-derived antioxidant with a specific membrane transporter that uptakes it into tissues susceptible to oxidative stress. We previously found that efficient dialytic clearance leads to marked ergothioneine depletion in patients on hemodialysis. Continuous renal replacement therapy (CRRT) provides higher time-averaged clearances of small solutes than hemodialysis. We therefore examined whether ergothioneine is depleted in patients receiving CRRT.
Methods
We first compared erythrocyte and plasma ergothioneine levels in 19 critically ill subjects maintained on CRRT for ≥2 days (CRRT), 18 critically ill subjects without kidney impairment (CI), and 15 healthy subjects (control). We then examined the degree to which initiation of CRRT reduced ergothioneine levels in a separate group of 11 subjects after ≥2 days on CRRT and measured ergothioneine in the effluent fluid to calculate its CRRT clearance.
Results
Compared to controls, erythrocyte and plasma ergothioneine levels were depleted in both critically ill subjects maintained on CRRT for 20 ± 26 days and critically ill subjects not on CRRT (erythrocyte: CRRT 226 ± 121 μM, CI 208 ± 132 μM, control 593 ± 568 μM; plasma: CRRT 0.52 ± 0.37 μM, CI 0.86 ± 0.83 μM, control 2.3 ± 1.7 μM). Initiation of CRRT in a separate group of 11 subjects significantly reduced the plasma level but not the erythrocyte level of ergothioneine after 3.4 ± 1.0 days. CRRT provided similar efficient clearances of ergothioneine, urea, and creatinine (31 ± 8, 38 ± 8, and 36 ± 10 mL/min).
Conclusions
Ergothioneine is significantly depleted in critically illness, and prolonged CRRT may worsen the depletion. Our findings motivate further investigation of the impact of ergothioneine depletion in critical illness.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Stanford University, Palo Alto, CA 94304, USA.
- Department of Medicine, Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA 94304, USA.
ORCID-Profile: Seolhyun Lee, Lindsey S Keo, Timothy W Meyer
Förderung
- NIDDK NIH HHS
- NINDS NIH HHS
- National Kidney Foundation
- National Institutes of Health
Zitieren
APA
Espinosa, W. A. V., Lee, S., Suba, J. K., Keo, L. S., Meyer, T. W., & Sirich, T. L. (2026). Depletion of the Antioxidant Ergothioneine by Critical Illness and Continuous Renal Replacement Therapy. Kidney and Dialysis, 6(3), 48. https://doi.org/10.3390/kidneydial6030048
Vancouver
Espinosa WAV, Lee S, Suba JK, Keo LS, Meyer TW, Sirich TL. Depletion of the Antioxidant Ergothioneine by Critical Illness and Continuous Renal Replacement Therapy. Kidney and Dialysis. 2026;6(3):48. doi:10.3390/kidneydial6030048
BibTeX
@article{Espinosa2026,
author = {Espinosa, William A Vasquez and Lee, Seolhyun and Suba, Josef K and Keo, Lindsey S and Meyer, Timothy W and Sirich, Tammy L},
title = {Depletion of the Antioxidant Ergothioneine by Critical Illness and Continuous Renal Replacement Therapy},
journal = {Kidney and Dialysis},
year = {2026},
volume = {6},
number = {3},
pages = {48},
doi = {10.3390/kidneydial6030048}
}
EUVIMED